🔗 Share this article

Chancellor Rachel Reeves has stated she is planning "focused measures to tackle cost of living pressures" in the upcoming Budget.

In comments to media outlets, she emphasized that reducing price rises is a joint duty of both the administration and the central bank.

The United Kingdom's price growth is forecast to be the most elevated among the Group of Seven advanced economies this year and next.

Potential Energy Bill Interventions

Sources suggest the government could take action to reduce energy bills, for example by reducing the current 5% rate of VAT charged on energy.

An additional approach is to cut some of the government charges currently included in bills.

Budgetary Constraints and Expert Expectations

The government will obtain the next assessment from the independent fiscal watchdog, the Office for Budget Responsibility, on Monday, which will reveal how much room there is for these actions.

The consensus from the majority of analysts is that Reeves will have to announce tax increases or spending cuts in order to adhere to her self-imposed borrowing rules.

Earlier on the same day, estimates showed there was a £22bn shortfall for the chancellor to fill, which is at the more modest range of projections.

"It is a shared job between the Bank of England and the government to continue tackling some of the drivers of inflation," the Chancellor informed reporters in the US capital, at the annual meetings of the IMF and global financial institution.

Tax Commitments and Global Concerns

While much of the focus has been on likely tax increases, the chancellor said the most recent figures from the fiscal watchdog had not altered her commitment to election pledges not to raise tax levels on earnings tax, sales tax or social security contributions.

She blamed an "unpredictable world" with increasing geopolitical and trade issues for the fiscal tax moves, probably to be focused on those "with the broadest shoulders."

International Economic Tensions

Commenting on worries about the United Kingdom's commercial links with the Asian nation she said: "The UK's national security always come first."

Recent statement by Chinese authorities to strengthen export controls on rare earths and other resources that are key for high-technology production led American leader Donald Trump to threaten an additional 100% import tax on goods from China, increasing the prospect of an all-out trade war between the two global powers.

The US Treasury Secretary labeled China's action "economic coercion" and "a global supply chain power grab."

Questioned on accepting the US offer to join its battle with the Asian nation, the Chancellor said she was "extremely troubled" by Chinese actions and encouraged the Chinese government "not to put up barriers and restrict access."

She said the move was "damaging for the global economy and generates additional obstacles."

"It is my opinion there are areas where we should address China, but there are also significant opportunities to sell into China's economy, including banking sector and other sectors of the economy. We've got to achieve that equilibrium right."

The chancellor also stated she was cooperating with other major economies "on our own essential resources strategy, so that we are less reliant."

Health Service Medicine Pricing and Investment

Reeves also admitted that the cost the National Health Service pays for medicines could increase as a consequence of ongoing discussions with the US government and its pharmaceutical firms, in return for lower tariffs and funding.

Some of the world's largest pharmaceutical manufacturers have said in recent statements that they are either delaying or scrapping operations in the United Kingdom, with several attributing the insufficient payments they are getting.

Recently, the government science advisor said the price the health service spends on drugs would must go up to prevent businesses and drug research funding departing from the UK.

Reeves stated to media: "It has been observed due to the payment system, that drug testing, recent pharmaceuticals have not been offered in the UK in the extent that they are in other EU nations."

"Our aim is to make sure that patients getting care from the NHS are able to receive the finest life-saving drugs in the globe. And so we are reviewing this situation, and... aiming to secure additional capital into Britain."